Imperforate hymen

Q17_IMPERFORATE_HYMEN

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q52.3 Cause of death: ICD-10 — Q52.3 2 out of 7 registries used, show all original rules.	58
4. Check minimum number of events None	58
5. Include endpoints None	58
6. Filter based on genotype QC (FinnGen only)	55

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

NAME	Q17_IMPERFORATE_HYMEN
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q523
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q523
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Imperforate hymen based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	55	55	-
Unadjusted period prevalence (%)	0.02	0.02	-
Median age at first event (years)	18.86	18.86	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
58: Matched controls
580

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Q52.3

ICD-10 Finland

Imperforate hymen

+∞

83.1

LFA10

NOMESCO Finland

Incision of imperforate hymen or remnant of hymen

+∞

55.3

N89.7

ICD-10 Finland

Haematocolpos

+∞

11.9

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

3.54

1.55

2.2

2.7

22.86

24.24

mmol/l

—

(3037467) Urinalysis macro (dipstick) panel - Urine

371

2.16

1.55

4.0

4.1

—

(3022313) Gas panel - Capillary blood

3.32

1.47

2.4

2.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

183

1.76

1.25

1.5

1.4

—

(3000494) Fungus identified in Specimen by Culture

2.35

1.12

1.4

—

(3013512) EKG study

2.03

1.12

2.4

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.08

1.08

1.2

1.4

—

(3011288) Drugs identified in Urine by Screen method

2.03

1.06

1.3

2.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

0.00

1.01

0.0

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1.84

0.94

1.4

1.5

371.20

142.95

iu/ml

—

(36304419) Bacteria [Presence] in Urine

121

0.52

0.91

2.9

2.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

196

1.59

0.91

2.7

3.1

—

(40768804) Tissue Pathology biopsy report

170

0.56

0.89

2.4

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

162

1.58

0.83

1.6

2.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

317

1.58

0.83

3.4

2.5

21.94

23.93

u/l

0.23

306

(3010813) Leukocytes [#/volume] in Blood

556

+∞

0.81

13.4

13.0

6.82

6.97

e9/l

0.17

543

(3000963) Hemoglobin [Mass/volume] in Blood

556

+∞

0.81

13.6

13.1

131.45

131.50

g/l

0.01

550

(3035941) MCH [Entitic mass]

555

+∞

0.81

13.4

12.9

29.47

29.81

0.77

548

(3024731) MCV [Entitic volume]

555

+∞

0.81

13.4

12.9

88.27

89.11

0.77

549

(3026361) Erythrocytes [#/volume] in Blood

555

+∞

0.81

13.5

13.0

4.46

4.44

e12/l

0.20

545

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

0.00

0.81

0.0

1.8

—

0.24

—

(3007461) Platelets [#/volume] in Blood

553

+∞

0.79

13.3

13.1

258.81

265.58

e9/l

0.41

544

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.73

0.79

1.6

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.93

0.70

1.4

2.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

0.00

0.61

0.0

1.4

—

151.69

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.60

0.0

1.3

—

(3005033) Fetal Nuchal fold Thickness US

1.58

0.60

1.2

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.58

0.60

1.2

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

100

1.53

0.59

1.1

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

100

1.53

0.59

1.1

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

100

1.53

0.59

1.1

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

100

1.53

0.59

1.1

1.5

—

(3044889) 12 lead EKG panel

228

0.69

0.56

2.1

—

(36660697) Celiac disease serology panel - Serum

1.48

0.55

1.7

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.52

0.52

1.3

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.49

0.51

1.5

1.6

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

140

0.65

0.51

2.6

2.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

264

1.37

0.51

1.7

1.8

—

(3018095) Leukocytes [#/volume] in Urine

170

0.70

0.47

2.9

3.1

10.81

51.66

e6/l

—

101

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

133

1.39

0.45

1.8

1.6

105.44

91.87

pmol/l

0.90

(3023368) Bacteria identified in Blood by Culture

1.41

0.43

1.4

2.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

0.00

0.42

0.0

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.51

0.41

1.2

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

2.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

0.41

0.0

2.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

3.6

—

1.13

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

3.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

120

1.34

0.34

1.7

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

483

1.46

0.34

7.2

8.1

18.87

18.93

mg/l

0.00

365

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.36

0.30

1.3

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

151

1.28

0.30

1.6

1.3

1.92

1.86

g/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

127

0.74

0.29

1.8

1.6

—

(3003338) MCHC [Mass/volume]

453

1.35

0.29

9.8

10.5

333.77

333.31

g/l

0.14

447

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

105

1.31

0.28

2.4

1.8

1.10

0.68

mg/l

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.28

0.27

1.7

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

320

1.24

0.27

2.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

192

1.23

0.26

1.4

1.5

—

(3008898) HLA-B27 [Presence]

1.34

0.24

1.2

1.1

—

(3022145) Colonoscopy Study observation

1.34

0.24

1.0

1.5

—

(40768797) Stomach Pathology biopsy report

1.27

0.23

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

108

1.26

0.22

1.3

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

127

1.24

0.22

1.3

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

118

1.25

0.21

2.1

1.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

0.00

0.21

0.0

1.7

—

22.65

—

(3014007) Fractional oxyhemoglobin in Arterial blood

0.00

0.21

0.0

5.7

—

95.58

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.28

0.21

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

1.0

—

1.67

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.20

0.0

3.1

—

54.57

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.20

0.0

1.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.20

0.0

3.1

—

3.27

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.20

0.20

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

224

0.84

0.20

2.4

2.2

—

(40761536) Microorganisms panel - Urine sediment

1.19

0.18

1.6

3.6

—

(3028300) Cannabinoids [Presence] in Urine

1.20

0.17

1.3

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

218

1.17

0.17

1.5

1.9

—

(3027944) Amphetamines [Presence] in Urine

1.18

0.17

1.0

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

1.18

0.17

1.3

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

0.78

0.17

2.8

1.5

1.48

1.27

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

113

1.19

0.14

2.7

2.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

114

1.18

0.13

3.7

3.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1.18

0.10

1.0

1.7

6.22

14.99

iu/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.12

0.10

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

1.13

0.08

1.3

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

266

1.10

0.08

2.1

1.9

—

(21494755) Public health laboratory ask at order entry panel

1.05

0.08

1.0

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

509

1.21

0.08

5.1

4.5

—

(3026008) Bacteria identified in Urine by Culture

163

0.89

0.08

1.7

2.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

108

1.14

0.08

2.5

6.4

0.98

1.05

inr

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

100

1.12

0.05

3.0

2.6

1276.96

4933.73

u/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

271

0.93

0.05

3.1

2.3

—

(3044640) Blood type and Crossmatch panel - Blood

160

1.09

0.05

2.0

1.7

—

(3003694) ABO and Rh group [Type] in Blood

260

1.07

0.04

2.0

1.9

—

(1761868) Lipid panel - Serum or Plasma

161

1.08

0.04

2.2

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

137

0.93

0.02

2.2

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

221

0.99

0.00

3.0

5.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

249

1.01

0.00

2.6

2.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

403

0.98

0.00

5.5

5.9

102.70

104.95

ml/min/173m2

0.23

292

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

168

1.02

0.00

1.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

116.50

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

0.00

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.00

0.0

1.0

—

112.17

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

0.00

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.0

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

6.88

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

0.00

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

11.12

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

40.82

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

0.31

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

2.93

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

0.00

0.0

1.0

—

(4034850) Laboratory test

0.00

0.0

11.5

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

162.67

—

(3021901) Oxygen saturation in Capillary blood

0.00

0.0

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.0

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

3.85

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.0

—

98.33

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

0.00

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

-0.00

0.0

1.9

—

4.85

—

(3010421) pH of Blood

0.00

-0.00

0.0

1.9

—

7.44

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

10.60

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

0.00

-0.00

0.0

6.9

—

0.74

—

(1616796) Gas panel - Central venous blood

0.00

-0.00

0.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1641.40

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.93

-0.00

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

0.96

-0.00

1.8

1.9

—

611.64

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

0.00

-0.00

0.0

1.7

—

30.71

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

0.00

-0.00

0.0

7.6

—

24.37

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

-0.00

0.0

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

0.00

-0.00

0.0

2.1

—

44.69

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

6.45

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

0.00

-0.00

0.0

6.9

—

0.73

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.9

—

(3018405) Lactate [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.6

—

1.50

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

287.80

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1.00

-0.00

1.7

1.5

187.83

325.54

mu/l

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

15.9

—

1469.38

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.34

—

(3020891) Body temperature

0.00

-0.00

0.0

2.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

0.00

-0.00

0.0

1.7

—

0.56

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

2.6

—

123.29

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

0.00

-0.00

0.0

1.9

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

0.00

-0.00

0.0

1.7

—

1.07

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

1.6

—

94.40

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.83

-0.00

1.4

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

-0.00

0.0

2.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

0.00

-0.00

0.0

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.92

-0.00

1.4

1.5

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3027008) Opiates [Presence] in Urine

1.03

-0.00

1.3

1.6

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

-0.00

0.0

1.9

—

11.51

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

-0.00

0.0

2.6

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

-0.00

0.0

1.6

—

1.20

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

8.0

—

838.38

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

-0.00

0.0

1.6

—

5.60

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: Q17_IMPERFORATE_HYMEN – Imperforate hymen

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Imperforate hymen

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Imperforate hymen (Q17_IMPERFORATE_HYMEN)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints